% | $
Quotes you view appear here for quick access.

Threshold Pharmaceuticals Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • tredleon tredleon Jun 9, 2009 12:35 PM Flag

    CEO Purchased in Open Market

    They may not have "final" phase II data on all the combo trials by the end of the year, but they will have alot more response data to review. From a cash perspective, with $17M on hand at the end of Q1 and a $5M per quarter run rate, they theoretically have enough to get them until the end of the year. But if they don't announce any intent/progress on partnering TH-302 (or finding some other non-dilutive capital source) by the Q2 earnings call, then investors will start bailing out assuming another round of dilution is coming. I would have to believe at this stage they would try to partner it, rather than do a share offering, but who knows?

0.4211+0.0206(+5.14%)May 24 4:00 PMEDT